Commit Biologics
PrivateLast Round
Seed
Jan 28, 2025
Total Funding Raised
$23.3M
Company Overview
Commit Biologics is a biotechnology company that develops a novel immunotherapy platform, BiCE™, to treat cancer and autoimmune diseases by activating the complement system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Commit Biologics Comps
Public and private peers based on sector, stage, and business model.
Commit Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 28, 2025 | ||||
| Seed | May 9, 2024 |
Commit Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korys | Seed |
| Novo Holdings | Seed |
| Bioqube Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2026
Intention to advance complement-powered immune engagers into clinical trials.
- Mar 16, 2026
Thomas Montgomery Andresen appointed as new Chief Executive Officer.
Commit Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Commit Biologics's valuation, stock price, and market status.
